Use of Biologics and Stem Cells in the Treatment of Other Inflammatory Diseases in the Horse

Vet Clin North Am Equine Pract. 2023 Dec;39(3):553-563. doi: 10.1016/j.cveq.2023.07.004. Epub 2023 Aug 20.

Abstract

Mesenchymal stem cells (MSCs) are powerful immunomodulatory cells that act via multiple mechanisms to coordinate, inhibit, and control the cells of the immune system. MSCs act as rescuers for various damaged or degenerated cells of the body via (1) cytokines, growth factors, and signaling molecules; (2) extracellular vesicle (exosome) signaling; and (3) direct donation of mitochondria. Several studies evaluating the efficacy of MSCs have used MSCs grown using xenogeneic media, which may reduce or eliminate efficacy. Although more research is needed to optimize the anti-inflammatory potential of MSCs, there is ample evidence that MSC therapeutics are worthy of further development.

Keywords: Endotoxemia; Inflammatory bowel disease; Laminitis; Mesenchymal stem cells; Recurrent airway obstruction.

Publication types

  • Review

MeSH terms

  • Animals
  • Biological Products* / metabolism
  • Biological Products* / therapeutic use
  • Cytokines / metabolism
  • Horse Diseases* / metabolism
  • Horse Diseases* / therapy
  • Horses
  • Immunomodulation
  • Mesenchymal Stem Cells* / metabolism

Substances

  • Biological Products
  • Cytokines